Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
ProShares Short Bitcoin Strategy ETF
BITI
$120M
| $1.57M | ﹤0.01% |
+23,860
| New | +$1.9M |
|
2102
Tenaya Therapeutics
TNYA
$162M
| $1.56M | ﹤0.01% |
482,325
+48,725
| +11% | +$105K |
|
2103
First Trust Smith Unconstrained Bond ETF
UCON
$3.28B
| $1.56M | ﹤0.01% |
+63,100
| New | +$1.52M |
|
2104
FTAI Infrastructure
FIP
$448M
| $1.56M | ﹤0.01% |
400,900
+91,600
| +30% | +$321K |
|
2105
iShares Global Tech ETF
IXN
$8.73B
| $1.55M | ﹤0.01% |
22,746
+11,646
| +105% | +$732K |
|
|
LIAN
2106
DELISTED
LianBio American Depositary Shares
LIAN
| $1.55M | ﹤0.01% |
346,000
+63,398
| +22% | +$218K |
|
2107
Voyager Therapeutics
VYGR
$187M
| $1.54M | ﹤0.01% |
183,100
-220,500
| -55% | -$1.6M |
|
|
EGRX
2108
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.54M | ﹤0.01% |
294,450
+38,298
| +15% | +$378K |
|
2109
AGF US Market Neutral Anti-Beta Fund
BTAL
$303M
| $1.54M | ﹤0.01% |
+90,773
| New | +$1.8M |
|
|
DFUS
2110
Dimensional US Equity ETF
DFUS
$21.5B
| $1.54M | ﹤0.01% |
29,700
+18,500
| +165% | +$895K |
|
2111
Backblaze
BLZE
$1.11B
| $1.54M | ﹤0.01% |
202,616
+79,000
| +64% | +$499K |
|
2112
Rocky Mountain Chocolate Factory
RMCF
$7.95M
| $1.54M | ﹤0.01% |
334,324
-5,639
| -2% | -$24.1K |
|
2113
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.76B
| $1.53M | ﹤0.01% |
+56,507
| New | +$1.48M |
|
2114
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.36B
| $1.53M | ﹤0.01% |
+18,100
| New | +$1.4M |
|
2115
iShares Russell Top 200 ETF
IWL
$2.27B
| $1.53M | ﹤0.01% |
13,300
+6,400
| +93% | +$692K |
|
|
LX
2116
LexinFintech Holdings
LX
$241M
| $1.53M | ﹤0.01% |
830,800
+357,126
| +75% | +$686K |
|
2117
ATS Corp
ATS
$2.08B
| $1.53M | ﹤0.01% |
35,300
-54,400
| -61% | -$2.11M |
|
2118
Establishment Labs
ESTA
$2.49B
| $1.53M | ﹤0.01% |
+58,934
| New | +$1.73M |
|
|
FLG
2119
Flagstar Bank National Association
FLG
$5.95B
| $1.53M | ﹤0.01% |
+49,729
| New | +$1.49M |
|
2120
Burford Capital
BUR
$938M
| $1.52M | ﹤0.01% |
97,600
+65,100
| +200% | +$870K |
|
|
LENZ
2121
LENZ Therapeutics
LENZ
$162M
| $1.52M | ﹤0.01% |
83,022
+45,251
| +120% | +$747K |
|
2122
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$924M
| $1.52M | ﹤0.01% |
34,550
+18,050
| +109% | +$761K |
|
2123
Omnicell
OMCL
$1.65B
| $1.52M | ﹤0.01% |
40,400
-177,443
| -81% | -$6.53M |
|
2124
NovoCure
NVCR
$1.85B
| $1.51M | ﹤0.01% |
+101,375
| New | +$1.36M |
|
2125
World Acceptance Corp
WRLD
$893M
| $1.51M | ﹤0.01% |
11,600
+6,600
| +132% | +$773K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.